estrone has been researched along with levonorgestrel in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (36.84) | 18.7374 |
| 1990's | 3 (15.79) | 18.2507 |
| 2000's | 4 (21.05) | 29.6817 |
| 2010's | 5 (26.32) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ban, F; Cherkasov, A; Fallahi, M; Hammond, GL; Santos-Filho, O; Thorsteinson, N | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL | 1 |
| Aedo, AR; Diczfalusy, E; Landgren, BM | 1 |
| Aedo, AR; Diczfalusy, E; Landgren, BM; Le Donne, M | 1 |
| Aedo, AR; Diczfalusy, E; Landgren, BM; Sundén, M | 1 |
| Varma, TR | 2 |
| Garrett, D; Wren, B | 1 |
| Bayard, F; Jozan, S; Kreitmann, B | 1 |
| Alvarez-Sánchez, F; Brache, V; Faundes, A; León, P; Schmidt, F | 1 |
| Baldwin, DM; Bergquist, CA; Castracane, VD; Lasley, B; Molland, JR; Morehead, DB | 1 |
| Bygdeman, M; Johannisson, E; Swahn, ML; Westlund, P | 1 |
| Mueck, AO; Seeger, H; Wallwiener, D | 1 |
| Safranow, K; Sieja, K; Stanosz, M; Stanosz, S; Zochowska, E | 1 |
| Aboulfadl, K; Barbeau, B; Broséus, R; Daneshvar, A; Prévost, M; Sauvé, S; Vincent, S | 1 |
| Chirinos, M; Durand, M; Koistinen, R; Larrea, F; Rodríguez, JL; Seppälä, M; Zambrano, E | 1 |
| Bourg, D; Bourg, L; Harrison, LI; Karara, AH; Melikian, AP; Morrison, D; Poola, N; Zurth, C | 1 |
| Albert, A; Appels, N; Coelingh Bennink, HJT; Fauser, BCJM; Laan, E; Termeer, HMM; Thijssen, JHH; van Lunsen, RHW; Zimmerman, Y | 1 |
1 review(s) available for estrone and levonorgestrel
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
8 trial(s) available for estrone and levonorgestrel
| Article | Year |
|---|---|
Pharmacokinetics and biotransformation of orally administered oestrone sulphate and oestradiol valerate in post-menopausal women.
Topics: Administration, Oral; Biotransformation; Estradiol; Estrogens; Estrone; Female; Half-Life; Humans; Levonorgestrel; Menopause; Middle Aged; Norgestrel; Random Allocation; Sex Hormone-Binding Globulin | 1990 |
Effect of orally administered oestrogens on gonadotrophin levels in post-menopausal women.
Topics: Administration, Oral; Drug Combinations; Estradiol; Estriol; Estrogens, Conjugated (USP); Estrone; Female; Follicle Stimulating Hormone; Humans; Levonorgestrel; Luteinizing Hormone; Menopause; Middle Aged; Norgestrel; Random Allocation | 1989 |
Effect of orally administered oestrogens on circulating oestrogen profiles in post-menopausal women.
Topics: Administration, Oral; Drug Combinations; Estradiol; Estriol; Estrogens; Estrogens, Conjugated (USP); Estrone; Female; Humans; Levonorgestrel; Menopause; Middle Aged; Norgestrel; Progesterone; Random Allocation | 1989 |
Effect of post-coital contraceptive methods on the endometrium and the menstrual cycle.
Topics: Administration, Oral; Contraceptives, Postcoital, Hormonal; Contraceptives, Postcoital, Synthetic; Danazol; Drug Combinations; Endometrium; Estrone; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Luteinizing Hormone; Menstruation; Pregnancy; Pregnanediol | 1996 |
Influence of modified transdermal hormone replacement therapy on the concentrations of hormones, growth factors, and bone mineral density in women with osteopenia.
Topics: Administration, Cutaneous; Administration, Oral; Bone Density; Bone Diseases, Metabolic; Collagen Type I; Estradiol; Estriol; Estrogen Replacement Therapy; Estrone; Female; Follicle Stimulating Hormone; Hormones; Humans; Insulin-Like Growth Factor I; Intercellular Signaling Peptides and Proteins; Levonorgestrel; Luteinizing Hormone; Middle Aged; Osteocalcin; Peptides; Progesterone; Prolactin; Statistics, Nonparametric | 2009 |
Hormonal evaluation and midcycle detection of intrauterine glycodelin in women treated with levonorgestrel as in emergency contraception.
Topics: Adult; Contraception, Postcoital; Contraceptive Agents, Female; Endometrium; Estradiol; Estrone; Female; Glycodelin; Glycoproteins; Gonadal Steroid Hormones; Humans; Levonorgestrel; Luteal Phase; Luteinizing Hormone; Menstrual Cycle; Ovarian Follicle; Ovulation; Pregnancy Proteins; Progesterone; Ultrasonography; Uterus; Young Adult | 2010 |
Pharmacokinetics of continuous once-a-week combination 17β-Estradiol/Low- or high-dose levonorgestrel transdermal delivery systems in postmenopausal women.
Topics: Administration, Cutaneous; Aged; Cross-Over Studies; Drug Combinations; Drug Delivery Systems; Estradiol; Estrogens; Estrone; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Middle Aged; Postmenopause; Sex Hormone-Binding Globulin | 2014 |
Maintaining physiological testosterone levels by adding dehydroepiandrosterone to combined oral contraceptives: I. Endocrine effects.
Topics: Adult; Androstenes; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Cross-Over Studies; Dehydroepiandrosterone; Double-Blind Method; Down-Regulation; Drug Combinations; Endocrine Glands; Estradiol; Estrone; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Netherlands; Reproducibility of Results; Sex Hormone-Binding Globulin; Solubility; Testosterone; Young Adult | 2017 |
10 other study(ies) available for estrone and levonorgestrel
| Article | Year |
|---|---|
An updated steroid benchmark set and its application in the discovery of novel nanomolar ligands of sex hormone-binding globulin.
Topics: Binding Sites; Binding, Competitive; Computer Simulation; Databases as Topic; Humans; Ligands; Linear Models; Models, Molecular; Predictive Value of Tests; Protein Binding; Quantitative Structure-Activity Relationship; Reproducibility of Results; Sex Hormone-Binding Globulin; Steroids | 2008 |
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat | 2016 |
Effect of long-term therapy with estrogen and progesterone on the endometrium of post-menopausal women.
Topics: Aged; Atrophy; Contraceptives, Oral, Combined; Dose-Response Relationship, Drug; Drug Therapy, Combination; Dydrogesterone; Endometrium; Estradiol; Estrogens; Estrogens, Conjugated (USP); Estrone; Female; Humans; Hyperplasia; Levonorgestrel; Menopause; Middle Aged; Norethindrone; Norgestrel; Progestins; Time Factors | 1985 |
The effect of low-dose piperazine oestrone sulphate and low-dose levonorgestrel on blood lipid levels in post-menopausal women.
Topics: Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Contraceptives, Oral, Combined; Estrone; Female; Humans; Levonorgestrel; Lipids; Menopause; Middle Aged; Norgestrel | 1985 |
Effect of oestrogen replacement therapy on blood coagulation factors in postmenopausal women.
Topics: Blood Coagulation; Blood Coagulation Factors; Blood Coagulation Tests; Contraceptives, Oral, Combined; Estradiol; Estradiol Congeners; Estrogens, Conjugated (USP); Estrone; Female; Humans; Levonorgestrel; Menopause; Middle Aged; Norethindrone; Norgestrel; Progesterone Congeners; Time Factors | 1983 |
Different effects of oestradiol, oestriol, oestetrol and of oestrone on human breast cancer cells (MCF-7) in long term tissue culture.
Topics: Breast Neoplasms; Cell Division; Cell Line; Estetrol; Estradiol; Estriol; Estrone; Female; Humans; Levonorgestrel; Norgestrel; Progesterone; Receptors, Progesterone; Tamoxifen | 1981 |
The effect of levonorgestrel and estrone rods on male reproductive function.
Topics: Adult; Contraceptives, Oral, Combined; Delayed-Action Preparations; Drug Synergism; Estrone; Follicle Stimulating Hormone; Humans; Levonorgestrel; Luteinizing Hormone; Male; Norgestrel; Sperm Count; Spermatogenesis; Testosterone | 1982 |
Immediate postpartum insertion of the norplant contraceptive device.
Topics: Adolescent; Adult; Contraceptive Agents, Female; Drug Implants; Estradiol; Estrone; Female; Humans; Incidence; Levonorgestrel; Postpartum Period; Pregnanediol; Progesterone; Prospective Studies; Puerperal Disorders; Sterilization, Tubal; Time Factors | 1996 |
Endogenous estradiol metabolism during treatment with oral contraceptives.
Topics: Adult; Contraceptives, Oral, Combined; Estradiol; Ethinyl Estradiol; Female; Humans; Hydroxyestrones; Levonorgestrel; Nandrolone; Norethindrone; Premenopause; Randomized Controlled Trials as Topic | 2004 |
Ozone oxidation of pharmaceuticals, endocrine disruptors and pesticides during drinking water treatment.
Topics: Caffeine; Endocrine Disruptors; Estradiol; Estriol; Estrogens; Estrone; Hydrogen-Ion Concentration; Levonorgestrel; Medroxyprogesterone; Molecular Structure; Norethindrone; Oxidation-Reduction; Ozone; Pesticides; Pharmaceutical Preparations; Progesterone; Water Pollutants, Chemical; Water Purification; Water Supply | 2009 |